LPIXEL Inc.

Established in 2014, LPIXEL is a leading provider of artificial intelligence-based image analysis technologies within the medical and life science industries.

LPIXEL’s flagship series of Software as a Medical Device (SaMD) products, ‘EIRL’, assists clinicians with the interpretation of medical images including radiological scans (X-ray, CT, MRI) and colonoscopy, and has performed over 12 million clinical analyses to date (as of June 2025).

In addition to clinical products, LPIXEL also accelerates R&D across the life sciences by delivering bespoke image analysis solutions to leading pharmaceutical and medical device companies with a focus on addressing challenges across all stages of the drug development pipeline, from drug discovery to clinical trials.

Our mission is to create a healthier future for all with medical AI.

By increasing healthcare efficiency and accuracy and decreasing the burden placed on clinicians, LPIXEL envisions a future where “doctor + AI” becomes the standard.